powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1447699145
Garabet Akoghlanian
M.D.
Infectious Disease
Houston,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
82.3
Quality
67.9
Cost
69.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.31%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
23
Beneficiaries
—
Total drug cost
$30K
Distinct drugs
2
Brand share
47.8%
Top prescribed drugs
Daptomycin
12 claims
Ertapenem Sodium
11 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
715
Unique beneficiaries
—
Total services
1,686
Distinct HCPCS
4
Medicare payment
$150K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 425 Infectious Disease providers in TX — top quintile (cohort median 589).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$292
Payment records
10
By payment type
Food and Beverage
$292
Top paying entities
Food and Beverage
$292